Navigation Links
Limb-sparing surgery may not provide better quality of life than amputation for bone cancer patients
Date:8/9/2009

imb-sparing surgery. However, amputation carries longer term costs related to artificial limb manufacture, maintenance, and replacement.

The authors say additional research is needed to provide a thorough comparison of amputation and limb-sparing surgery in different types of patients with bone and soft tissue sarcomas. "Future studies that include function, health-related quality of life, economics, and stratification of patients by age will be useful contributions to decision-making by patients, health care providers and administrators," said Dr. Wunder.


'/>"/>

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Susies Big Adventure Explores Plastic Surgery In Saudi Arabia
2. Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
3. Lexi-Comp ONLINE™ for Oral Surgery
4. Surgery, Sham Equal in Treating Compression Fracture Pain
5. Mobile Surgery International Assembles Team of Nationally Recognized Orthopedic Surgeons
6. Tennessee's New Life Center for Bariatric Surgery Launches Comprehensive Website Reaching out to Sufferers of Morbid Obesity
7. Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances
8. Neck surgery for cervical spine disorders found to alleviate associated headaches
9. Neck Surgery for Cervical Spine Disorders Found to Alleviate Associated Headaches
10. New Surgical Device Revolutionizes Face Lifts, Abdominoplasty and Breast Reduction Surgery Promising Patients Quicker Recovery Time, Less Pain and Fewer Bruises
11. Men Around the World Seek Cosmetic Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... After suffering from women,s hair loss for almost... and she,s sharing her progress and the secret beh...ugh the release of her video diaries which include... her treatment. , (PRWeb ...ferer Zsanett Siklosi has released the video diari...
(Date:11/23/2009)...TargetIndividualsintheRecommendedPriorityGroups ,...--TheDepartmentofHealthannouncedtodaytheywillcondu...eHealthCentersinDelaware,Lancaster,andLehighcounti...inewillbeadministeredforfreetoindividualsinthereco...hevaccine.Thedepartmentasksthatonlyindividualsinth...
(Date:11/23/2009)...care professionals enjoy a pay raise for a job wel...s for health care performance may actually backfir... performance ratings for 25 medical groups across ...unch of a statewide pay-for-performance program in... productivity. , Reporting in the December ed...
(Date:11/23/2009)...t woman to head the agency, said lives could be at...s) -- The fallout from last week,s controversial r...e mammogram testing for breast cancer continues, w...of Health advising women to ignore the guidelines....ause unequivocally this will increase the number o...
(Date:11/23/2009)...caretofinance"reform"isamoraloutrage ,, WASHI...eDemocratsmovedforwardtobeginthedebateontheirhealt...pporterstronggrassrootssenioradvocacygroup,iscalli...testthemassivecutstoMedicare.RetireSafePresidentTh...issuesliketaxes,abortion,andimmigration,whilethesi...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2
...enwood Systems, LLC ( http://www.GlenwoodSystems.c...h seamlessly integrates EMR and Practice Manage...ess. The product has been designed to reduce the ... Waterbury, CT (Vocus) February 26...
... affordable High Voltage Piezo Amplifier (QPA200) ...l applications, and to facilitate transducer evalu... Medford, MA (PRWEB) February 26, 2009 -- P...coustically cancel noise, or to replace solenoid v...
...n the retina that is responsible for maintaining t...as been imaged in a living retina for the first ti...yer could help doctors identify the onset of many ... ., "Our goal is to figure out why macular degene...
...harmaNet Development Group, Inc. (the "Company") (...evelopment services, today reported preliminary ne... 2008, of $1.6 million, or $0.08 per diluted share...provided in this press release is subject to recor...
...or February 26, 2009 at 10:00 a.m. EST , , , EA...ls, Inc. (Nasdaq: SVNT ) today reported financia...mber 31, 2008. For the fourth quarter of 2008, th...ad a net loss of $84.2 million, or $1.57 per share...
...ookings and continued positive cash flow from oper... AMCS ), a leader in radiology and medical image...ted unaudited financial results for the fourth qua...evenue : Total revenue for the fourth quarter of 2...
Other Medicine News:Health News:Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete 2Health News:Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete 3Health News:Amped Up Piezos Are On The Move - Driving Piezos with an Affordable High Voltage Piezo Amplifier QPA200 2Health News:Amped Up Piezos Are On The Move - Driving Piezos with an Affordable High Voltage Piezo Amplifier QPA200 3Health News:'Dark cells' of living retina imaged for the first time 2Health News:'Dark cells' of living retina imaged for the first time 3Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 2Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 3Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 4Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 5Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 6Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 7Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 8Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 9Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 10Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 11Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 12Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 13Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 14Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 15Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 16Health News:PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results 17Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 2Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 3Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 4Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 5Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 6Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 7Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 8Health News:Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results 9Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 2Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 3Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 4Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 5Health News:AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008 6
(Date:11/23/2009)...PRNewswire/--BioTrendsResearchGroup,Inc.releasedWa...esecondinamulti-phasesyndicatedmarketresearchproje...me,throughthefirstsixmonthsofproductavailability.E...rom50uniqueNephrologistsandqualitativeinformationf...me,obstaclestouse,reasonstouse,typicalpatienttypes...
(Date:11/23/2009)...23/PRNewswire/--AMDLASERSannouncedthisweekthatitco...artneringwithprestigiousindustry-leaderDr.LarryRos...llbetheexclusivesofttissuediodelaserusedduringalli...tothetop2%ofdentists. ,, (Photo: http://www.new...iswithgreatpleasurethatIproudlyannounceourpartners...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--RaptorPharmaceuticalCor...uncedthepresentationofclinicaltrialdataonNGX426,th...tereceptorantagonist,atthe12thInternationalConfere...ldonNovember20-21inSanFrancisco.Theresultsofthestu...siologyattheCenterforPainMedicineoftheUniversityof...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 1Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 2Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 3Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 1Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 2Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 3Dementia More Likely With One Subtype of HIV 55639 1
...EGF Antibodies Inhibited Tumor Growth By, ..., - Peregrine,s Antibodies that Selectively Inhibi...ges over Non-Selective Approaches - , - These Resu...ibody Support , Advancing Peregrine,s Anti-VEGF Pr...TUSTIN, Calif., April 16, 2007,/PRNewswire-FirstCa...
...ing, BLOOMFIELD, N.J., April 16, 2007 /PRNewswire-... that in vivo and in vitro,preclinical data presen...ncer Research (AACR) Annual Meeting show that ONCO...wth of non-small cell,lung cancer (NSCLC) and brea... apoptosis and reduced lactate,levels by ranpirnas...
Other Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 2Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 3Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 4Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 5Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 2Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of,Non-Small Cell Lung Cancer, Breast Cancer Cells 3
Gentamicin, 50 mg/ml
GENTAMICIN SULFATE, 1000X
...e is effective against gram positive and gram nega...ng with bacterial protein synthesis by binding to ...g concentration of 50 mg/L is generally non-toxic ...entler alternative to penicillin and steptomycin. ...
Gibco Gentamicin Reagent Solution (10 mg/ml) liquid
Medicine Products: